Skip to main content

Holtzman Douglas's Form 4 filing

Icosavax, Inc. (ICVX) · filed Apr 5, 2023

Accession no.
0001209191-23-023467
Filed
Apr 5, 2023
Trade date
Apr 3, 2023
Filing delay
2 days
Rule 10b5-1 plan
Checked

This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market sales total $124.4K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Holtzman DouglasCIK 0001874371Officer (Chief Scientific Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Apr 3, 2023Common StockMOption exerciseAcquired+20,443$1.04+$21,260.72310,497Direct
Apr 3, 2023Common StockSSaleDisposed−20,143$6.08−$122,469.44290,354Direct
Apr 3, 2023Common StockSSaleDisposed−300$6.56−$1,968290,054Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Apr 3, 2023Common StockMOption exerciseDisposed−20,443$0.00$044,977Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)